Scientific Advisory Board

Dr. Pascal Schneider is Maître d’Enseignement et de Recherche of Biochemistry at the University of Lausanne. He studied biochemistry and obtained a PhD in 1992 at the University of Lausanne. He performed a post-doc with Prof. MAJ Ferguson at the University of Dundee, Scotland, and then joined the research group of Prof. Jurg Tschopp at the Department of Biochemistry, University of Lausanne, where he has been appointed assistant professor in 2002 and senior lecturer and researcher in 2006. Ligands and receptors of the TNF family are his major research interests, a field where is considered a world leading expert authoring several peer-reviewed papers and reviews

Prof. Jieping Zhu is full professor of organic chemistry and head of the Laboratory of synthesis and natural products (LSPN) at the EPF where he leads a research program aiming at the development of new tools and innovative strategies for organic synthesis. After earning a master’s degree in China in 1987, he completed his doctorate at Université de Paris-Sud and joined the French National Center for Scientific Research (CNRS). He subsequently worked at the “Institut de Chimie des Substances Naturelles” (ICSN) in Gif-sur-Yvette (France), where he developed a research program aimed at total synthesis of complex molecules. In 2000 he was appointed CNRS research director at the ICSN heading a laboratory of 25 scientists. Professor Zhu’s scientific program covered the fields of stereoselective total synthesis of natural products and compounds of biological interest, development of multi-compound reactions, combinatorial chemistry, and new methods of synthesis.

Dr. Gerardo Turcatti, is Maître d’Enseignement et de Recherche, at the EPFL where he directs the academic screening platform (Biomolecular Screening Facility) he created in 2006. His lab performs drug-discovery related research using chemicals, natural products and genome-wide siRNA collections. Previously he co-founded and acted as CTO of Manteia S.A., a Swiss-based company where he co-invented and developed revolutionary high throughput DNA sequencing technologies which are currently commercialized by Illumina Inc. Prior to this, Dr Turcatti had a long multidisciplinary career in R&D divisions of Biotechnology and Pharmaceutical companies. Dr. Turcatti earned his Master in Chemical Engineering at the University of Geneva and his PhD in Chemistry and Biochemistry at the EPFL where he received the award for the best doctoral thesis in 1995. He has expertise in several Chemical Biology-related areas such as Drug Screening, Bio-analytical Chemistry, Receptor Biochemistry, DNA and Protein Chemistry

Prof. Alain-François Grogg is full Professor of Process Engineering and Physical Chemistry at the Institute Life Technologies of the University of Applied Sciences Western Switzerland in Sion. Since 1995 his Phytoresources group works at the valorization of medicinal properties of the plants having developed strong phytoanalytic capabilities to perform the fractionation of plant extracts and identification of active compounds. Hisgroup has patented sustainable on-line extraction processes in partnership with PhytoArk. Dr. Grogg earned his PhD in 1989 at the EPFL in the area of surface chemistry and spent a two years post doctoral position at the Institut für Biotechnologie at Forschungszentrum Jülich (earlier KFA-J) in the area of animal cells technology.

Prof. Bruno Schnyder is full Professor at the University of Applied Sciences (HES-SO) in Sion at the Institute of Life Technologies, teaching and researching in biochemistry, microbiology, molecular biology, and comparative immunology. Prof. Schnyder has 20 years of research & development experience in life science technologies. He has previously worked for Dupont, Merck and various start-up companies in Switzerland and France and in 1998 he participated in the inventor team of the Institute of Biopharmaceutical Research (IBR Inc.). Bruno studied biochemistry, immunology and microbiology at the ETH in Zurich where he got his Ph.D. in 1994. After a post-doctoral work in USA at Dupont Merck Inc., and two group leaderships at the University Fribourg (CH) and University d’Orléans (F), he wrote his Habilitation (HDR) in Life Sciences Immunology at the University of Orleans in 2006. He has experience in establishing preclinical, toxicology and screening assays with bacteria and human cell cultures, as well as co-culturing of both together in host-pathogen interaction assays and bactericidal assays.